Lansinoh debuts new Italian Momma brand
BOSTON — Drug Store News editor-in-chief Rob Eder interviewed Lansinoh Labs VP sales Michelle McLaughlin here at NACDS Marketplace about the company’s leading position in the natural feeding category, and an exciting new line of products from Europe, which Lansinoh acquired this year and currently is launching to U.S. retailers.
Momma, Lansinoh’s new line of feeding accessories from Italy, brings style and function to the category, with brilliant colors and rounded shapes to help babies develop motor skills, McLaughlin told DSN.TV for a special video interview that will air on DrugStoreNews.com early next month.
Key features of the Momma line include:
- Round shapes that are easy for babies to hold;
- Playful, rocking movements that engage babies and encourage motor skill development;
- Bright colors to attract babies’ attention;
- Contemporary designs;
- Hygienic covers and closures that make travel easy, and the round shape that eliminates contact with unsanitary surfaces; and
- Nonslip materials that offer babies more control while learning to feed.
“Lansinoh has a proven history of raising the bar on the natural feeding category,” McLaughlin said, noting that 80% of new mothers now are initiating breast-feeding with their newborns, marking a major increase in recent years.
Certainly, Lansinoh, which has been a major pioneer of the space at retail, has played a key role in that growth. “Lansinoh brought natural feeding mainstream with the introduction of HPA Lanolin in 1985,” McLaughlin said, “and in 2000, we launched the first polymer-based disposable nursing pad, and we now have [more than a] 50% market share.”
With the addition of the Momma brand, the company now represents a solution for moms for the first two years of babies’ lives.
Prestige Brands expands sales management, customer planning departments
NEW YORK — Prestige Brands has expanded its sales management team and customer planning group.
The appointments include:
David Howenstine, who joins Prestige as VP sales from Pfizer. At Pfizer, he served in a variety of leadership roles in field sales, customer development and category management;
Jayne Reiss, who previously worked at Warner Lambert, Brach, Insight Pharmaceutical and Matrixx, where she managed the national accounts sales force, has joined Prestige as VP national accounts;
Jeff Burnett, who joined Prestige Brands in April, was appointed VP field sales, responsibile for all food and dollar store customers, Prestige said; and
Bill Maher, who joined Prestige in March, serves as as VP sales and channel planning. In this role, Bill will lead our category management, shopper insights and trade marketing efforts for Prestige.
Prestige recently expanded its portfolio with the acquisition of several brands, including Pediacare, Luden’s, Efferdent and Dramamine.
Adding PycnoQ10 to treatment for heart failure patients boosts blood flow to organs
HOBOKEN, N.J. — A recent study published in Panminerva Medica found that a pycnogenol and coenzyme-Q10 combination (PycnoQ10) taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.
As a result, the oxygen-rich blood supply to the organs improves, and patients become more physically energetic.
Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree and has been clinically proven to improve endothelial function and blood flow.
"Many conditions that lead to heart failure cannot be reversed, but heart failure can often be medically managed with good results," stated Gianni Belcaro, a lead researcher of the study. "This study shows that a combination of Pycnogenol and CoQ10 offers an effective, natural solution as adjunct for heart health management."
The 12-week single-blinded, placebo-controlled observational study was conducted at Chieti-Pescara University in Italy and investigated the effectiveness of pycnogenol and kaneka CoQ10 (PycnoQ10) supplementation in 53 patients. Patients were between the ages of 54 and 68 years and had mild to moderate hypertension, with stable congestive heart failure.
The physical abilities of patients improved substantially as evidenced by 3.3 times longer walking distance on a treadmill in patients taking PycnoQ10, versus marginal improvement in a control group.